Sign in
4

Changes in Ownership

NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-23-009889

Options or other derivatives

  • Chief Medical Officer acquired 60,985 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ROBERTS EIRY · Chief Medical Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-02-13 Grant or award : show line 1 in the form Stock Option +52,532 52,532 D
2023-02-13 Grant or award : show line 2 in the form Restricted Stock Unit +8,453 8,453 D
Loading xslF345X03/doc4.xml…